The effects of growth hormone supplementation in poor ovarian responders undergoing In vitro fertilization or Intracytoplasmic sperm injection: A systematic review and meta-analysis of randomized controlled trials

To evaluate the effect of growth hormone (GH) supplementation on outcomes of in vitro fertilization (IVF) or Intracytoplasmic sperm injection (ICSI) for women with poor ovarian response. Relevant randomized controlled trials (RCTs) were obtained through search in several databases including PubMed,...

Full description

Saved in:
Bibliographic Details
Published inTurkish journal of obstetrics and gynecology Vol. 21; no. 3; p. 208
Main Authors Zakerinasab, Faezeh, Behfar, Qumars, Parsaee, Reza, Mojeni, Fariba Arbab, Ansari, Arina, Deravi, Niloofar, Khademi, Reza
Format Journal Article
LanguageEnglish
Published Turkey 04.09.2024
Subjects
Online AccessGet full text

Cover

Loading…
Abstract To evaluate the effect of growth hormone (GH) supplementation on outcomes of in vitro fertilization (IVF) or Intracytoplasmic sperm injection (ICSI) for women with poor ovarian response. Relevant randomized controlled trials (RCTs) were obtained through search in several databases including PubMed, Scopus, Clinicaltrials.gov, Google Scholar, and Cochrane Library. Outcome measures included live birth rate, clinical pregnancy rate, cycle cancelation rate, number of retrieved oocytes, number of transferred embryos, total dose of gonadotropin, duration of gonadotropin treatment, and peak estradiol level. Additionally, a meta-regression analysis was carried out to determine any potential linear relationships between these outcomes and IVF success. After analyzing 18 RCTs comprising of 1870 patients, the study found that GH supplementation improved the number of retrieved oocytes [standardized mean difference (SMD), 0.65; 95% confidence interval (CI), 0.29-1.00] and transferred embryos group (SMD, 0.80, 95% CI, 0.39, 1.21) as well as peak E2 level (SMD, 1.20; 95% CI, 0.59, 1.81). While reduced the total dose and duration of gonadotropin treatment (SMD, -0.82, 95% CI, -1.25, -0.39, and SMD, -0.63, 95% CI, -1.04, -0.22, respectively). The meta-regression analysis found no linear relationship between clinical pregnancy, live birth rate, or cycle cancelation rate and the outcomes measured (p>0.1). Based on the available evidence, GH supplementation appears to improve the outcomes of IVF or ICSI in women with poor response. However, there is a need for further RCTs with larger sample sizes to determine the cost-effectiveness of adding GH to conventional protocols of IVF/ICSI for treating infertility in women with poor ovarian response.
AbstractList To evaluate the effect of growth hormone (GH) supplementation on outcomes of in vitro fertilization (IVF) or Intracytoplasmic sperm injection (ICSI) for women with poor ovarian response. Relevant randomized controlled trials (RCTs) were obtained through search in several databases including PubMed, Scopus, Clinicaltrials.gov, Google Scholar, and Cochrane Library. Outcome measures included live birth rate, clinical pregnancy rate, cycle cancelation rate, number of retrieved oocytes, number of transferred embryos, total dose of gonadotropin, duration of gonadotropin treatment, and peak estradiol level. Additionally, a meta-regression analysis was carried out to determine any potential linear relationships between these outcomes and IVF success. After analyzing 18 RCTs comprising of 1870 patients, the study found that GH supplementation improved the number of retrieved oocytes [standardized mean difference (SMD), 0.65; 95% confidence interval (CI), 0.29-1.00] and transferred embryos group (SMD, 0.80, 95% CI, 0.39, 1.21) as well as peak E2 level (SMD, 1.20; 95% CI, 0.59, 1.81). While reduced the total dose and duration of gonadotropin treatment (SMD, -0.82, 95% CI, -1.25, -0.39, and SMD, -0.63, 95% CI, -1.04, -0.22, respectively). The meta-regression analysis found no linear relationship between clinical pregnancy, live birth rate, or cycle cancelation rate and the outcomes measured (p>0.1). Based on the available evidence, GH supplementation appears to improve the outcomes of IVF or ICSI in women with poor response. However, there is a need for further RCTs with larger sample sizes to determine the cost-effectiveness of adding GH to conventional protocols of IVF/ICSI for treating infertility in women with poor ovarian response.
To evaluate the effect of growth hormone (GH) supplementation on outcomes of in vitro fertilization (IVF) or Intracytoplasmic sperm injection (ICSI) for women with poor ovarian response. Relevant randomized controlled trials (RCTs) were obtained through search in several databases including PubMed, Scopus, Clinicaltrials.gov, Google Scholar, and Cochrane Library. Outcome measures included live birth rate, clinical pregnancy rate, cycle cancelation rate, number of retrieved oocytes, number of transferred embryos, total dose of gonadotropin, duration of gonadotropin treatment, and peak estradiol level. Additionally, a meta-regression analysis was carried out to determine any potential linear relationships between these outcomes and IVF success. After analyzing 18 RCTs comprising of 1870 patients, the study found that GH supplementation improved the number of retrieved oocytes [standardized mean difference (SMD), 0.65; 95% confidence interval (CI), 0.29-1.00] and transferred embryos group (SMD, 0.80, 95% CI, 0.39, 1.21) as well as peak E2 level (SMD, 1.20; 95% CI, 0.59, 1.81). While reduced the total dose and duration of gonadotropin treatment (SMD, -0.82, 95% CI, -1.25, -0.39, and SMD, -0.63, 95% CI, -1.04, -0.22, respectively). The meta-regression analysis found no linear relationship between clinical pregnancy, live birth rate, or cycle cancelation rate and the outcomes measured (p>0.1). Based on the available evidence, GH supplementation appears to improve the outcomes of IVF or ICSI in women with poor response. However, there is a need for further RCTs with larger sample sizes to determine the cost-effectiveness of adding GH to conventional protocols of IVF/ICSI for treating infertility in women with poor ovarian response.To evaluate the effect of growth hormone (GH) supplementation on outcomes of in vitro fertilization (IVF) or Intracytoplasmic sperm injection (ICSI) for women with poor ovarian response. Relevant randomized controlled trials (RCTs) were obtained through search in several databases including PubMed, Scopus, Clinicaltrials.gov, Google Scholar, and Cochrane Library. Outcome measures included live birth rate, clinical pregnancy rate, cycle cancelation rate, number of retrieved oocytes, number of transferred embryos, total dose of gonadotropin, duration of gonadotropin treatment, and peak estradiol level. Additionally, a meta-regression analysis was carried out to determine any potential linear relationships between these outcomes and IVF success. After analyzing 18 RCTs comprising of 1870 patients, the study found that GH supplementation improved the number of retrieved oocytes [standardized mean difference (SMD), 0.65; 95% confidence interval (CI), 0.29-1.00] and transferred embryos group (SMD, 0.80, 95% CI, 0.39, 1.21) as well as peak E2 level (SMD, 1.20; 95% CI, 0.59, 1.81). While reduced the total dose and duration of gonadotropin treatment (SMD, -0.82, 95% CI, -1.25, -0.39, and SMD, -0.63, 95% CI, -1.04, -0.22, respectively). The meta-regression analysis found no linear relationship between clinical pregnancy, live birth rate, or cycle cancelation rate and the outcomes measured (p>0.1). Based on the available evidence, GH supplementation appears to improve the outcomes of IVF or ICSI in women with poor response. However, there is a need for further RCTs with larger sample sizes to determine the cost-effectiveness of adding GH to conventional protocols of IVF/ICSI for treating infertility in women with poor ovarian response.
Author Ansari, Arina
Behfar, Qumars
Mojeni, Fariba Arbab
Deravi, Niloofar
Zakerinasab, Faezeh
Khademi, Reza
Parsaee, Reza
Author_xml – sequence: 1
  givenname: Faezeh
  orcidid: 0000-0002-2011-393X
  surname: Zakerinasab
  fullname: Zakerinasab, Faezeh
  organization: Mashhad University of Medical Sciences, Department of Obstetrics and Gynecology, Mashhad, Iran
– sequence: 2
  givenname: Qumars
  orcidid: 0000-0001-5217-924X
  surname: Behfar
  fullname: Behfar, Qumars
  organization: University of Cologne Faculty of Medicine and University Hospital Cologne, Department of Neurology, Cologne, Germany
– sequence: 3
  givenname: Reza
  orcidid: 0009-0005-8349-3238
  surname: Parsaee
  fullname: Parsaee, Reza
  organization: Shiraz University of Medical Sciences, Transplant Research Center, Shiraz, Iran
– sequence: 4
  givenname: Fariba Arbab
  orcidid: 0000-0002-1468-8008
  surname: Mojeni
  fullname: Mojeni, Fariba Arbab
  organization: Mazandaran University of Medical Sciences, School of Medicine, Student Research Committee, Sari, Iran
– sequence: 5
  givenname: Arina
  orcidid: 0000-0003-2625-9603
  surname: Ansari
  fullname: Ansari, Arina
  organization: North Khorasan University of Medical Sciences, School of Medicine, Student Research Committee, Bojnurd, Iran
– sequence: 6
  givenname: Niloofar
  orcidid: 0000-0002-6965-6927
  surname: Deravi
  fullname: Deravi, Niloofar
  organization: Shahid Beheshti University of Medical Sciences, School of Medicine, Tehran, Iran
– sequence: 7
  givenname: Reza
  orcidid: 0009-0001-5857-8003
  surname: Khademi
  fullname: Khademi, Reza
  organization: Mashhad University of Medical Sciences, Faculty of Medicine Student Research Committee, Mashhad, Iran
BackLink https://www.ncbi.nlm.nih.gov/pubmed/39228251$$D View this record in MEDLINE/PubMed
BookMark eNo1kUFvEzEQhX0ooqX0L8AcuWywvZvdNbeqohCpEpdyjhx7NnFkexbbmyr9n_wfDC2nNxq9782T5h27iBSRsY-Crzo5dJ_Lkexqrz1GyivJZbdaK9V1F-xKik41qpXykt3kfOSci3EYlJBv2WWrpBzlWlyx348HBJwmNCUDTbBP9FQOcKAU6iHIyzx7DBiLLo4iuAgzUQI66eR0hIR5pmgxZVj-yp5c3MMmwsmVRDBhKs675xe4cptYkjbnQrPXOTgDecYUauyxFqieL3AL-ZwLhoqYGn9y-AQ6WghYdKOj9ufs_jVNdUvBPaMFQzWWvK9jqbV8fs_eTFXw5lWv2c_7r49335uHH982d7cPjRG8E83EJbf90Fou6sJIg9OoezlyNQkx9bYfuebKKiF2ehj73lSIt7pTO2vG1pj2mn16yZ0T_Vowl21w2aD3OiItedsKzte9UGKo1g-v1mUX0G7n5IJO5-3_V7R_AHmdlks
ContentType Journal Article
Copyright Copyright© 2024 The Author. Published by Galenos Publishing House on behalf of Turkish Society of Obstetrics and Gynecology.
Copyright_xml – notice: Copyright© 2024 The Author. Published by Galenos Publishing House on behalf of Turkish Society of Obstetrics and Gynecology.
DBID NPM
7X8
DOI 10.4274/tjod.galenos.2024.59944
DatabaseName PubMed
MEDLINE - Academic
DatabaseTitle PubMed
MEDLINE - Academic
DatabaseTitleList PubMed
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
ExternalDocumentID 39228251
Genre Journal Article
GroupedDBID 7X7
8FI
8FJ
ABUWG
ADBBV
AFKRA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BCNDV
BENPR
BPHCQ
BVXVI
CCPQU
FYUFA
GROUPED_DOAJ
HMCUK
HYE
IAO
ICW
IEBAR
IHR
ITC
NPM
PIMPY
PQQKQ
PROAC
RPM
UKHRP
7X8
ID FETCH-LOGICAL-c1041-f020d673d01c10c2cef8a62809f11f6d680a09d911ba7866c04103a49bdc83cc3
ISSN 2149-9322
IngestDate Sat Oct 26 04:08:19 EDT 2024
Thu Oct 24 10:04:51 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords IVF
meta-analysis
Growth hormone
systematic review
gonadotropin
Language English
License Copyright© 2024 The Author. Published by Galenos Publishing House on behalf of Turkish Society of Obstetrics and Gynecology.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c1041-f020d673d01c10c2cef8a62809f11f6d680a09d911ba7866c04103a49bdc83cc3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0002-1468-8008
0009-0005-8349-3238
0000-0002-6965-6927
0000-0003-2625-9603
0009-0001-5857-8003
0000-0002-2011-393X
0000-0001-5217-924X
PMID 39228251
PQID 3100561917
PQPubID 23479
ParticipantIDs proquest_miscellaneous_3100561917
pubmed_primary_39228251
PublicationCentury 2000
PublicationDate 2024-Sep-04
20240904
PublicationDateYYYYMMDD 2024-09-04
PublicationDate_xml – month: 09
  year: 2024
  text: 2024-Sep-04
  day: 04
PublicationDecade 2020
PublicationPlace Turkey
PublicationPlace_xml – name: Turkey
PublicationTitle Turkish journal of obstetrics and gynecology
PublicationTitleAlternate Turk J Obstet Gynecol
PublicationYear 2024
SSID ssj0001877912
Score 2.3272088
Snippet To evaluate the effect of growth hormone (GH) supplementation on outcomes of in vitro fertilization (IVF) or Intracytoplasmic sperm injection (ICSI) for women...
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
StartPage 208
Title The effects of growth hormone supplementation in poor ovarian responders undergoing In vitro fertilization or Intracytoplasmic sperm injection: A systematic review and meta-analysis of randomized controlled trials
URI https://www.ncbi.nlm.nih.gov/pubmed/39228251
https://www.proquest.com/docview/3100561917
Volume 21
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnZ1ba9swFMdF0kLpy9i9u4Uz2FtI51t82Vs7WtpBSldSCHsJkizn0sYKjlNovue-z44kx3ayBba9GGPHjsj5RTpH-p8jQj5FzIpdP0wwTA26GKCojdxj1-ngn08EViQY17U7e1f-xa33bdAdNJqNmmppmbNjvvpjXsn_WBWvoV1Vluw_WLZ8KV7Ac7QvHtHCePxrG9cEGSMMqfNxe4xuqETfcaE27DTi8LWicS5l1pYPGB9Tlcai5LFKyKw3w81G0qgH2g-TPJPtRCmu74s0TSVbv1TzwPwxl3P0uJWkXhUZn-Frp1rOlZok9-3S0EZxPBM57dBaARQcImM5m6xEvFbL3-Op3kNkUXeY-8vsThVdqlW4kAy_QW0sYMpLjx5TwTcWB37QO5XUSBdULzadU7ES5az3qRgnRlT-XanLy5DiGs-pUSXdiFU5WPXkVOhdr_A12YTR9knGKKvPlTieFoN5VZfqYDzYQY91o_83GdoF5269M9cVJ34bZDwM5JGMfIoDnBrFU6nKvjvecTeKTC3LGnrzmWYPvVCdJFyNuqUWcn2rSfYdVe2_NuOk5wnDIIj0on3ZeCNTVM34vKMRh-Rg_drdkZP2oPpPyZMi9IETw_Ez0hDpc3LQK8QdL8hPxBkKnEEmYHCGAmfYwhkmKSicocAZKpyhwhkuU9A4wwbOgM9t4wwaZyhx_gInUMEMBmZA4mADZtXSCmaoYAYD80tye37W_3rRKXYd6XDb8uxOggFU7AdubNl4gTtcJCH1ndCKEttO_NgPLWpFMToJjAah73N8yHKpF7GYhy7n7iuyl-LPckSgy8IgSnzGLJZ4ji2oFXPuMBF5NKQ8CN6Qj2vbDLFXV0t1NBVyuRiqZTeMbCIbP_PaGG04N-VnhmvLvt155x05rOh_T_bybCk-oO-csxZpBoOgRfZPz66ub1oatV-cFtbM
link.rule.ids 315,786,790,27946,27947,31744,33769
linkProvider National Library of Medicine
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+effects+of+growth+hormone+supplementation+in+poor+ovarian+responders+undergoing+In+vitro+fertilization+or+Intracytoplasmic+sperm+injection%3A+A+systematic+review+and+meta-analysis+of+randomized+controlled+trials&rft.jtitle=Turkish+journal+of+obstetrics+and+gynecology&rft.au=Zakerinasab%2C+Faezeh&rft.au=Behfar%2C+Qumars&rft.au=Parsaee%2C+Reza&rft.au=Mojeni%2C+Fariba+Arbab&rft.date=2024-09-04&rft.issn=2149-9322&rft.volume=21&rft.issue=3&rft.spage=208&rft_id=info:doi/10.4274%2Ftjod.galenos.2024.59944&rft_id=info%3Apmid%2F39228251&rft.externalDocID=39228251
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2149-9322&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2149-9322&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2149-9322&client=summon